Log in to save to my catalogue

A population study of clinically actionable genetic variation affecting drug response from the Middl...

A population study of clinically actionable genetic variation affecting drug response from the Middl...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c314b59c9cbb499c9aff4aa493e6fdd4

A population study of clinically actionable genetic variation affecting drug response from the Middle East

About this item

Full title

A population study of clinically actionable genetic variation affecting drug response from the Middle East

Publisher

London: Nature Publishing Group UK

Journal title

Npj genomic medicine, 2022-02, Vol.7 (1), p.10-10, Article 10

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Clinical implementation of pharmacogenomics will help in personalizing drug prescriptions and alleviate the personal and financial burden due to inefficacy and adverse reactions to drugs. However, such implementation is lagging in many parts of the world, including the Middle East, mainly due to the lack of data on the distribution of actionable ph...

Alternative Titles

Full title

A population study of clinically actionable genetic variation affecting drug response from the Middle East

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c314b59c9cbb499c9aff4aa493e6fdd4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c314b59c9cbb499c9aff4aa493e6fdd4

Other Identifiers

ISSN

2056-7944

E-ISSN

2056-7944

DOI

10.1038/s41525-022-00281-5

How to access this item